A Phase 2 Placebo Controlled, Clinical Trial Designed to Assess the Efficacy, Safety and Dose Response Characterisation of STS01 for the Treatment of Mild-moderate Alopecia Areata (AA)
Conditions: Alopecia Areata Interventions: Drug: STS01; Drug: Placebo Sponsors: Soterios Ltd Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 7, 2024 Category: Research Source Type: clinical trials
Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata
Conditions: Alopecia Areata Interventions: Drug: Simvastatin; Drug: Mometasone Furoate; Procedure: Fractional CO2 laser Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2024 Category: Research Source Type: clinical trials
Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial Alopecias
Conditions: Lichen Planopilaris of Scalp; Alopecia Areata Interventions: Device: Venus Glow Sponsors: University of Minnesota Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)
Conditions: Alopecia Areata Interventions: Drug: Rezpegaldesleukin; Drug: Placebo Sponsors: Nektar Therapeutics Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata
Conditions: Alopecia Areata Interventions: Drug: Lactic Acid; Drug: vit D; Drug: Triamcinolone Acetonide; Drug: Saline Sponsors: Zagazig University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEases
Conditions: Psoriasis; Alopecia Areata; Hidradenitis Suppurativa; Vitiligo; Atopic Dermatitis Interventions: Behavioral: HautKompass Sponsors: Universit ätsklinikum Hamburg-Eppendorf; German Federal Ministry of Education and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo
Conditions: Alopecia Areata; Vitiligo; Atopic Dermatitis; Psoriasis Interventions: Other: Observational Sponsors: Blueskin AS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Systemic Treatments for Alopecia Areata Registry
Conditions: Alopecia Areata; Alopecia Totalis; Alopecia Universalis; Hair Loss; Hair Diseases; Alopecia; Alopecia Drugs; Autoimmune Diseases Sponsors: Erasmus Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Litfulo Capsules Special Investigation
Conditions: Alopecia Areata Interventions: Drug: LITFULO Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi.
Conditions: Alopecia Areata; Alopecia Totalis; Alopecia Universalis Interventions: Drug: Tofacitinib Sponsors: Jinnah Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
Evaluation of Latanoprost Combined With Fractional Erbium- YAG Laser
Conditions: Alopecia Areata Interventions: Drug: Latanoprost Sponsors: Egymedicalpedia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Oral Tofacitinib in the Treatment of Alopecia Areata
Conditions: Extensive Alopecia Areata Interventions: Drug: Oral Tofacitinib citrate Sponsors: Services Institute of Medical Sciences, Pakistan Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
Excimer Light(308) Therapy for Resistant Alopecia Areata
Conditions: Alopecia Areata Interventions: Device: excimer light Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials
Safety and Efficacy of Oral NXC-736 in Adult Participants With Severe Alopecia Areata
Conditions: Alopecia Areata Interventions: Drug: NXC736; Drug: Placebo Sponsors: NEXTGEN Bioscience Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials
Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata.
Conditions: Alopecia Areata Interventions: Drug: Betamethasone Valerate 0.1% Cream; Drug: Pentoxifylline; Drug: Metformin Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
